Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rehan Ahmad

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|June 28, 2021
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancerWagdy M Eldehna, Rofaida Salem, Zainab M Elsayed, et al.
Bioimpacts : BI|March 31, 2025
Unlocking the potential of lumateperone and novel anti-psychotics for schizophreniaS Rehan Ahmad, Md Zeyaullah, Abdullah M AlShahrani, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 21, 2020
Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cellsWagdy M Eldehna, Mahmoud F Abo-Ashour, Tarfah Al-Warhi, et al.
Cancer Cell International|April 24, 2020
Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signalingOmar Al-Obeed, Adila Salih El-Obeid, Sabine Matou-Nasri, et al.
Oncogene|June 10, 2022
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatmentYoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, et al.
Molecular Cancer Therapeutics|July 17, 2019
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast CancerTsuyoshi Hata, Hasan Rajabi, Masaaki Yamamoto, et al.
Reproduction in Domestic Animals = Zuchthygiene|January 25, 2024
Kisspeptin stimulates oestradiol biosynthesis by upregulating steroidogenic transcripts and proliferation markers in the bubaline granulosa cells in vitroRenu Sharma, Manas Kumar Patra, Thejaswini Meda Puttanarsappa, et al.
Nature Communications|April 11, 2020
TGFβ suppresses CD8<sup>+</sup> T cell expression of CXCR3 and tumor traffickingAndrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Molecular Cancer Research : MCR|November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast CancerNami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Translational Oncology|February 7, 2026
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancerVenkatesh Rajamanickam, Noah D Simons, Wesley Rosales, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Journal of Enzyme Inhibition and Medicinal Chemistry|June 28, 2021
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancerWagdy M Eldehna, Rofaida Salem, Zainab M Elsayed, et al.
Bioimpacts : BI|March 31, 2025
Unlocking the potential of lumateperone and novel anti-psychotics for schizophreniaS Rehan Ahmad, Md Zeyaullah, Abdullah M AlShahrani, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 21, 2020
Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cellsWagdy M Eldehna, Mahmoud F Abo-Ashour, Tarfah Al-Warhi, et al.
Cancer Cell International|April 24, 2020
Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signalingOmar Al-Obeed, Adila Salih El-Obeid, Sabine Matou-Nasri, et al.
Oncogene|June 10, 2022
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatmentYoshihiro Morimoto, Atsushi Fushimi, Nami Yamashita, et al.
Molecular Cancer Therapeutics|July 17, 2019
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast CancerTsuyoshi Hata, Hasan Rajabi, Masaaki Yamamoto, et al.
Reproduction in Domestic Animals = Zuchthygiene|January 25, 2024
Kisspeptin stimulates oestradiol biosynthesis by upregulating steroidogenic transcripts and proliferation markers in the bubaline granulosa cells in vitroRenu Sharma, Manas Kumar Patra, Thejaswini Meda Puttanarsappa, et al.
Nature Communications|April 11, 2020
TGFβ suppresses CD8<sup>+</sup> T cell expression of CXCR3 and tumor traffickingAndrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Molecular Cancer Research : MCR|November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast CancerNami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Translational Oncology|February 7, 2026
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancerVenkatesh Rajamanickam, Noah D Simons, Wesley Rosales, et al.
Pageof 14